Cantel Medical (CMD) Stock Price, News & Analysis

Company Overview

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Key Stats

• Today's Range: $80.37 to $80.37
• 50-Day Range: $80.37 to $88.79
• 52-Week Range: $39.40 to $89.76
• Volume: N/A
• Average Volume: 626,604 shs
• Market Capitalization: $3.58 billion
• P/E Ratio: 69.28
• Dividend Yield: 0.26%
• Price Target: N/A
• Consensus Rating: N/A

CMD Stock Analysis - Frequently Asked Questions

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) announced its earnings results on Monday, March, 8th. The company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.29. The business's quarterly revenue was up 1.9% on a year-over-year basis.

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cantel Medical investors own include Meta Platforms (META), NVIDIA (NVDA), M&T Bank (MTB), Johnson & Johnson (JNJ), Lam Research (LRCX), Pfizer (PFE) and Exxon Mobil (XOM).

Company Calendar

• Last Earnings: 3/08/2021
• Today: 12/22/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NYSE:CMD
• CUSIP: N/A
• CIK: 19446
• Web: www.cantelmedical.com
• Phone: 973-890-7220
• Fax: N/A
• Employees: 3,669
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $1.65
• Trailing P/E Ratio: 69.28
• Forward P/E Ratio: 30.68
• P/E Growth: 1.63
• Net Income: $13.71 million
• Net Margins: 4.72%
• Pretax Margin: N/A
• Return on Equity: 12.13%
• Return on Assets: 4.45%

Debt

• Debt-to-Equity Ratio: 1.16
• Current Ratio: 2.72
• Quick Ratio: 2.00

Sales & Book Value

• Annual Sales: $1.02 billion
• Price / Sales: 3.52
• Cash Flow: $3.38 per share
• Price / Cash Flow: 23.78
• Book Value: $17.31 per share
• Price / Book: 4.64

Miscellaneous

• Outstanding Shares: 44,513,000
• Free Float: N/A
• Market Cap: $3.58 billion
• Optionable: Optionable
• Beta: 1.55